Key result
No-reflow following primary percutaneous coronary intervention for ST elevation myocardial infarction was an independent predictor of 12-month mortality (HR 1.95).
Why the study?
Does no-reflow post primary PCI for STEMI predict 12-month mortality?
Population
781 patients who underwent primary percutaneous coronary intervention for ST elevation myocardial infarction…
Comparison
No-reflow at the end of the primary PCI procedure vs Normal reflow at the end of the primary PCI…
Design
Cohort
Follow-up
12 months
Authors
Loading...
May identify higher 12-month mortality risk after STEMI PCI; leaves open whether no-reflow prevention improves survival.
Cohort (n=764)
No
Does no-reflow post primary PCI for STEMI predict 12-month mortality?
Effect estimate: HR 1.95 (95% CI 1.04-3.59)
Absolute Event Rate: 13% vs 6%
p-value: p=0.037
No-reflow after primary PCI for STEMI occurs in 25% of cases, is driven by older age, high thrombus burden, and delayed presentation, and independently predicts 12-month mortality.
Mazhar et al. (2015) conducted a cohort in ST elevation myocardial infarction (STEMI) (n=764). No-reflow (TIMI < 3) vs. Normal flow was evaluated on All-cause mortality at 12 months (HR 1.95, 95% CI 1.04-3.59, p=0.037). No-reflow following primary percutaneous coronary intervention for ST elevation myocardial infarction was an independent predictor of 12-month mortality (HR 1.95).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: